Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

USPHARMA WINDLAS

  • FDA Approval
  • Jan. 30, 2024, 09:41 UTC
  • 33
  • 0 comments

FDA approve AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Jan. 30, 2024, 09:41 UTC
  • 33
  • 0 comments

FDA approve MOXIFLOXACIN HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 30, 2024, 09:41 UTC
  • 32
  • 0 comments

FDA approve PERINDOPRIL ERBUMINE

Comment Full text

GUERBET

  • FDA Approval
  • Jan. 29, 2024, 17:23 UTC
  • 36
  • 0 comments

FDA approve GADOTERATE MEGLUMINE

Comment Full text

BRACCO

  • FDA Approval
  • Jan. 29, 2024, 17:14 UTC
  • 32
  • 0 comments

FDA approve GADOBENATE DIMEGLUMINE

Comment Full text

BAYER HLTHCARE

  • FDA Approval
  • Jan. 29, 2024, 17:14 UTC
  • 33
  • 0 comments

FDA approve GADOBUTROL

Comment Full text

BRACCO

  • FDA Approval
  • Jan. 29, 2024, 17:14 UTC
  • 33
  • 0 comments

FDA approve GADOBENATE DIMEGLUMINE

Comment Full text

BRACCO

  • FDA Approval
  • Jan. 29, 2024, 17:02 UTC
  • 34
  • 0 comments

FDA approve GADOTERIDOL

Comment Full text

GE HEALTHCARE

  • FDA Approval
  • Jan. 29, 2024, 16:03 UTC
  • 32
  • 0 comments

FDA approve GADODIAMIDE

Comment Full text

GE HEALTHCARE

  • FDA Approval
  • Jan. 29, 2024, 16:03 UTC
  • 34
  • 0 comments

FDA approve GADODIAMIDE

Comment Full text
  • Previous
  • 563
  • 564
  • 565
  • 566
  • 567
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235883)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143334)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin